Tela Bio Inc (TELA)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$0.82+5.19%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · TELA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Revenues | 79.9 | 80.3 | 69.3 | 58.5 | 41.4 | 29.5 | 18.2 | 15.4 |
| Gross Profit | 54.2 | 54.3 | 46.5 | 40.1 | 27.0 | 18.8 | 11.2 | 9.3 |
| Operating Expenses & Income | ||||||||
| R&D Expenses | 9.5 | 9.2 | 8.8 | 9.6 | 8.9 | 6.7 | 4.3 | 4.2 |
| Operating Income | (34.0) | (33.8) | (34.1) | (44.1) | (39.0) | (29.5) | (25.3) | (19.2) |
| Earnings from Continuing Operations | ||||||||
| Interest Expense | — | 5.2 | 5.3 | 5.2 | 4.1 | 3.6 | 3.6 | 3.6 |
| Other Non-Operating Income / Expenses | (6.9) | (4.8) | (3.9) | (2.6) | (5.3) | (3.8) | (3.5) | — |
| EBT, Incl. Unusual Items | (40.9) | (38.6) | (38.0) | (46.7) | (44.3) | — | — | — |
| Income Tax Expense | — | 0.2 | (0.1) | — | — | — | — | — |
| Net Income | ||||||||
| Net Income | (41.1) | (38.8) | (37.8) | (46.7) | (44.3) | (33.3) | (28.8) | (22.4) |
| Per Share | ||||||||
| Basic EPS | (0.72) | (0.83) | (1.33) | (2.04) | (2.72) | (2.30) | (2.23) | — |
| Diluted EPS | (0.72) | (0.83) | (1.33) | (2.04) | (2.72) | (2.30) | (2.23) | — |
| Revenue per Share | 1.39 | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 57.4 | 46.9 | 28.5 | 22.9 | 16.3 | 14.5 | 12.9 | — |
| Diluted Weighted Avg Shares | 57.4 | 46.9 | 28.5 | 22.9 | 16.3 | 14.5 | 12.9 | — |
| Supplemental | ||||||||
| EBIT | (34.0) | (33.8) | (34.1) | (44.1) | (39.0) | (29.5) | (25.3) | (19.2) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.